Results 131 to 140 of about 2,801 (152)

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

Anticholesteremic agents, statins, modulate monocyte activation in cultured human THP-1 cells

, 2013
Fumihide Takano, Changxiao Bi, Yasuhito Ishigaki, Haruno Yoshida, Chikai Sakurada, Takashi Takahashi   +5 more
openalex  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

[CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].

Minerva medica, 1996
A, GIULIANI, V, SAMMARTINO
openaire   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

[Further clinical research on a new anticholesteremic agent (4-diphenylyl ethyl-acetic acid)].

, 1958
G Annoni
openalex  

[Anticholesteremic agents and omega-3 fatty acids].

, 2003
Knud Landmark, Ivar Aursnes
openalex  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

[Unethical article on anticholesteremic agents].

, 2002
Paal Røiri
openalex